Alpha Cognition (ACOG) Stock Forecast: StockMap's 2-Week Call
ACOG stock forecast: StockMap's model leans Underperform on Alpha Cognition for the two weeks after the Nov 19 close, toward ACOG trailing the growth index. It is a lean inside the no-call band, not a call, and not a price target. Right in 2 of 5 two-week windows on ACOG since Aug 31; by chance, a call on the same dates was right 56% of the time.
Alpha Cognition last closed at $8.85, +2.91% on the session.
Against the IVW growth benchmark the position is +5.24% over the forecast window.
Alpha Cognition's market cap is $195.07M as of November 19, 2026.
Leans down ↘: a small lean, not a call · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is -27 (too close to call).
Where ACOG sits: sized by market cap, coloured by the day's move.
The read is built from 15 underlying insights — 2 bullish and 13 bearish.
Agreement across those insights is 87%.
33 daily calls for ACOG so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.
On the fundamentals StockMap ranks Alpha Cognition in the 17th percentile on return on equity, where 100 is best.
Alpha Cognition is classified under Health Care / Biotechnology.
StockMap tracks Alpha Cognition as the 237th largest of the 394 companies it covers in the Biotechnology industry, part of the Health Care sector.
Across that group the current two-week reads are 200 Moderate Underperform, 134 Neutral, 43 Strong Underperform and 17 Moderate Outperform.
On that composite Alpha Cognition ranks 197th of 394 in the group, against a group median of -0.27.